Market Overview:
The global vaccine market grew at a CAGR of around 8% during 2014-2019 reaching US$ 37 Billion in 2019. From a public health perspective, vaccines represent among the most important inventions in human history. A vaccine refers to a biological component that stimulates the production of antibodies against several pathogens present in the body. It is generally produced by using disease-causing agents and chemical drugs that act as antigens in disease prevention. Vaccines are primarily available in the form of conjugate vaccines, inactivated vaccines, live attenuated vaccines, recombinant vaccines, and toxoid vaccines. They help in preventing various life-threatening diseases, including measles, polio, diphtheria, meningitis, influenza, tetanus, rotavirus, hepatitis, etc. As a result, vaccines are widely adopted for several immunization procedures, across hospitals, clinics, and vaccination centers, and for research purposes in academic and clinical laboratories.
The high prevalence of several infectious diseases is primarily driving the demand for vaccines. The growing consumer awareness towards effective immunization for eradicating various infections is further catalyzing the market growth. Moreover, the introduction of several vaccination programs by governments across various endemic regions is also propelling the demand for vaccines. Additionally, the market is also driven by the growing number of child deaths due to various infectious diseases, such as hepatitis, polio, measles, rubella, etc., particularly across the under-developed countries. The increasing involvement of several global organizations, such as the WHO, UNICEF, World Bank, Bill & Melinda Gates Foundation, etc. for developing adequate vaccination facilities in the endemic regions, is further catalyzing the product demand. Several pharmaceutical companies are focusing on the development of new and improved vaccines by accelerating the clinical trials of various pipeline drugs. Extensive R&D activities pertaining to the immunization of several fatal diseases, such as AIDS, Ebola, Hepatitis C, paratyphoid fever, etc., are also expected to fuel the market growth. The outbreak of the COVID-19 pandemic, leading to around half a million global deaths (as of June 2020), is currently creating opportunities for a novel vaccine against COVID-19. Looking forward, IMARC Group expects the global vaccine market to reach US$ 57 Billion by 2025.
Key Market Segmentation:
IMARC Group provides an analysis of the key trends in each sub-segment of the global vaccine market report, along with forecasts for growth at the global, regional and country level from 2020-2025. Our report has categorized the market based on region, technology, patient type, indication, administration, route of administration, product type, treatment type, end-user, and distribution channel.
Breakup by Technology:
- Conjugate Vaccines
- Inactivated and Subunit Vaccines
- Live Attenuated Vaccines
- Recombinant Vaccines
- Toxoid Vaccines
- Others
Breakup by Patient Type:
Breakup by Indication:
- Bacterial Diseases
- Meningococcal Disease
- Pneumococcal Disease
- Diphtheria/Tetanus/Pertussis (DPT)
- Tuberculosis
- Haemophilus Influenzae (Hib)
- Typhoid
- Others
- Viral Diseases
- Hepatitis
- Influenza
- Human Papillomavirus (HPV)
- Measles/Mumps/Rubella (MMR)
- Rotavirus
- Herpes Zoster
- Varicella
- Japanese Encephalitis
- Rubella
- Polio
- Rabies
- Dengue
- Others
Breakup by Route of Administration:
- Intramuscular and Subcutaneous Administration
- Oral Administration
- Others
Breakup by Product Type:
- Multivalent Vaccine
- Monovalent Vaccine
Breakup by Treatment Type:
- Preventive Vaccine
- Therapeutic Vaccine
Breakup by End User:
- Hospitals
- Clinics
- Vaccination Centres
- Academic and Research Institutes
- Others
Breakup by Distribution Channel:
- Hospital Pharmacies
- Retail Pharmacies
- Institutional Sales
- Others
Breakup by Region:
- North America
- Asia Pacific
- China
- Japan
- India
- South Korea
- Australia
- Others
- Europe
- Germany
- France
- United Kingdom
- Italy
- Spain
- Russia
- Others
- Latin America
- Middle East and Africa
- Turkey
- GCC Countries
- Israel
- Others
Competitive Landscape:
The competitive landscape of the industry has also been examined with some of the key players being Abbott Laboratories, Astellas Pharma Inc., AstraZeneca Plc, Bharat Biotech International, Bavarian Nordic A/S, CSL Limited, Daiichi Sankyo Company Limited, Emergent BioSolutions Inc., GlaxoSmithKline Plc, Inovio Pharmaceuticals Inc., Johnson & Johnson, Merck & Co. Inc., Mitsubishi Tanabe Pharma Corporation (Mitsubishi Chemical Holdings Corporation), Novavax Inc., Panacea Biotec Ltd., Pfizer Inc., Sanofi Pasteur SA (Sanofi SA), Serum Institute of India Pvt. Ltd. and Takeda Pharmaceutical Company Limited.
Key Questions Answered in This Report:
The global vaccine market was worth around US$ 37 Billion in 2019.
According to the estimates by IMARC Group, the global vaccine market will exhibit moderate growth during 2020-2025.
The rising prevalence of infectious diseases and the growing awareness about effective immunization are among the significant factors impelling the global vaccine market growth.
The increasing focus on the development of new and improved vaccines, along with the introduction and continual launch of various vaccination programs by governments of numerous countries, is bolstering the market growth.
Due to the rapid spread of the coronavirus disease (COVID-19) and the increasing death rate, there is an urgent need to develop novel vaccines to provide effective treatment to patients. Consequently, several organizations are engaging in research and development (R&D) activities, which, in turn, is positively influencing the market growth.
Based on the technology, the market has been classified into conjugate, inactivated and subunit, live attenuated, recombinant, toxoid, and other vaccines.
On the basis of the patient type, the market has been bifurcated into pediatric and adults.
The market has been analyzed on the basis of the indication into bacterial diseases [meningococcal, pneumococcal, diphtheria/tetanus/pertussis (DPT), tuberculosis, Hemophilus influenzae (Hib), typhoid and others] and viral diseases [Hepatitis, influenza, human papillomavirus (HPV), measles/mumps/rubella (MMR), rotavirus, herpes zoster, varicella, Japanese encephalitis, rubella, polio, rabies, dengue and others].
Based on the route of administration, the market has been categorized into intramuscular and subcutaneous administration, oral administration and others.
On the basis of the product type, the market has been divided into multivalent and monovalent vaccines.
The market has been analyzed on the basis of the treatment type into preventive and therapeutic vaccines.
Based on the end user, the market has been classified into hospitals, clinics, vaccination centers, academic and research institutes, and others.
On the basis of the distribution channel, the market has been segregated into hospital pharmacies, retail pharmacies, institutional sales and others.
Region-wise, the market has been classified into North America (the United States and Canada); Asia Pacific (China, Japan, India, South Korea, Australia and others); Europe (the United Kingdom, Germany, France, Italy, Spain, Russia and others); Latin America (Brazil, Mexico and others); and the Middle East and Africa (Turkey, GCC Countries, Israel and others).
Leading industry players are Abbott Laboratories, Astellas Pharma Inc., AstraZeneca PLC, Bharat Biotech International Ltd., Bavarian Nordic A/S, CSL Ltd., Daiichi Sankyo Company, Limited, Emergent BioSolutions Inc., GlaxoSmithKline Plc, Inovio Pharmaceuticals, Inc., Johnson & Johnson, Inc., Merck & Co. Inc., Mitsubishi Tanabe Pharma Corporation (Mitsubishi Chemical Holdings Corporation), Novavax Inc., Panacea Biotec Ltd., Pfizer Inc., Sanofi Pasteur SA (Sanofi SA), Serum Institute of India Pvt. Ltd. and Takeda Pharmaceutical Company Limited.
1 Preface
2 Scope and Methodology
2.1 Objectives of the Study
2.2 Stakeholders
2.3 Data Sources
2.3.1 Primary Sources
2.3.2 Secondary Sources
2.4 Market Estimation
2.4.1 Bottom-Up Approach
2.4.2 Top-Down Approach
2.5 Forecasting Methodology
3 Executive Summary
4 Introduction
4.1 Overview
4.2 Key Industry Trends
4.2.1 Regulatory Landscape
4.2.1.1 United States
4.2.1.2 Canada
4.2.1.3 European Union
4.2.1.4 China
4.2.1.5 India
4.2.1.6 Japan
4.2.1.7 South Korea
4.2.1.8 Australia
4.2.1.9 Russia
4.2.1.10 Brazil
4.2.1.11 Mexico
4.2.1.12 Turkey
4.2.1.13 GCC Countries
4.2.1.14 Israel
4.2.2 Product Pipeline for New Vaccines
4.2.1 Product Pipeline for HIV
4.2.2 Product Pipeline for Zika Virus
4.2.3 Product Pipeline for Ebola Virus
4.2.4 Product Pipeline for COVID-19
5 Global Vaccine Market
5.1 Market Overview
5.2 Market Performance
5.3 Impact of COVID-19
5.4 Market Forecast
6 Market Breakup by Technology
6.1 Conjugate Vaccines
6.1.1 Market Trends
6.1.2 Market Forecast
6.2 Inactivated and Subunit Vaccines
6.2.1 Market Trends
6.2.2 Market Forecast
6.3 Live Attenuated Vaccines
6.3.1 Market Trends
6.3.2 Market Forecast
6.4 Recombinant Vaccines
6.4.1 Market Trends
6.4.2 Market Forecast
6.5 Toxoid Vaccines
6.5.1 Market Trends
6.5.2 Market Forecast
6.6 Others
6.6.1 Market Trends
6.6.2 Market Forecast
7 Market Breakup by Patient Type
7.1 Paediatric
7.1.1 Market Trends
7.1.2 Market Forecast
7.2 Adult
7.2.1 Market Trends
7.2.2 Market Forecast
8 Market Breakup by Indication
8.1 Bacterial Diseases
8.1.1 Market Trends
8.1.2 Major Types
8.1.2.1 Meningococcal Disease
8.1.2.1.1 Market Trends
8.1.2.1.2 Market Forecast
8.1.2.2 Pneumococcal Disease
8.1.2.2.1 Market Trends
8.1.2.2.2 Market Forecast
8.1.2.3 Diphtheria/Tetanus/Pertussis (DPT)
8.1.2.3.1 Market Trends
8.1.2.3.2 Market Forecast
8.1.2.4 Tuberculosis
8.1.2.4.1 Market Trends
8.1.2.4.2 Market Forecast
8.1.2.5 Haemophilus Influenzae (Hib)
8.1.2.5.1 Market Trends
8.1.2.5.2 Market Forecast
8.1.2.6 Typhoid
8.1.2.6.1 Market Trends
8.1.2.6.2 Market Forecast
8.1.2.7 Others
8.1.2.7.1 Market Trends
8.1.2.7.2 Market Forecast
8.1.3 Market Forecast
8.2 Viral Diseases
8.2.1 Market Trends
8.2.2 Major Types
8.2.2.1 Hepatitis
8.2.2.1.1 Market Trends
8.2.2.1.2 Market Forecast
8.2.2.2 Influenza
8.2.2.2.1 Market Trends
8.2.2.2.2 Market Forecast
8.2.2.3 Human Papillomavirus (HPV)
8.2.2.3.1 Market Trends
8.2.2.3.2 Market Forecast
8.2.2.4 Measles/Mumps/Rubella (MMR)
8.2.2.4.1 Market Trends
8.2.2.4.2 Market Forecast
8.2.2.5 Rotavirus
8.2.2.5.1 Market Trends
8.2.2.5.2 Market Forecast
8.2.2.6 Herpes Zoster
8.2.2.6.1 Market Trends
8.2.2.6.2 Market Forecast
8.2.2.7 Varicella
8.2.2.7.1 Market Trends
8.2.2.7.2 Market Forecast
8.2.2.8 Japanese Encephalitis
8.2.2.8.1 Market Trends
8.2.2.8.2 Market Forecast
8.2.2.9 Rubella
8.2.2.9.1 Market Trends
8.2.2.9.2 Market Forecast
8.2.2.10 Polio
8.2.2.10.1 Market Trends
8.2.2.10.2 Market Forecast
8.2.2.11 Rabies
8.2.2.11.1 Market Trends
8.2.2.11.2 Market Forecast
8.2.2.12 Dengue
8.2.2.12.1 Market Trends
8.2.2.12.2 Market Forecast
8.2.2.13 Others
8.2.2.1.13 Market Trends
8.2.2.1.13 Market Forecast
8.2.3 Market Forecast
9 Market Breakup by Route of Administration
9.1 Intramuscular and Subcutaneous Administration
9.1.1 Market Trends
9.1.2 Market Forecast
9.2 Oral Administration
9.2.1 Market Trends
9.2.2 Market Forecast
9.3 Others
9.3.1 Market Trends
9.3.2 Market Forecast
10 Market Breakup by Product Type
10.1 Multivalent Vaccine
10.1.1 Market Trends
10.1.2 Market Forecast
10.2 Monovalent Vaccine
10.2.1 Market Trends
10.2.2 Market Forecast
11 Market Breakup by Treatment Type
11.1 Preventive Vaccine
11.1.1 Market Trends
11.1.2 Market Forecast
11.2 Therapeutic Vaccine
11.2.1 Market Trends
11.2.2 Market Forecast
12 Market Breakup by End User
12.1 Hospitals
12.1.1 Market Trends
12.1.2 Market Forecast
12.2 Clinics
12.2.1 Market Trends
12.2.2 Market Forecast
12.3 Vaccination Centres
12.3.1 Market Trends
12.3.2 Market Forecast
12.4 Academic and Research Institutes
12.4.1 Market Trends
12.4.2 Market Forecast
12.5 Others
12.5.1 Market Trends
12.5.2 Market Forecast
13 Market Breakup by Distribution Channel
13.1 Hospital Pharmacies
13.1.1 Market Trends
13.1.2 Market Forecast
13.2 Retail Pharmacies
13.2.1 Market Trends
13.2.2 Market Forecast
13.3 Institutional Sales
13.3.1 Market Trends
13.3.2 Market Forecast
13.4 Others
13.4.1 Market Trends
13.4.2 Market Forecast
14 Market Breakup by Region
14.1 North America
14.1.1 United States
14.1.1.1 Market Trends
14.1.1.2 Market Forecast
14.1.2 Canada
14.1.2.1 Market Trends
14.1.2.2 Market Forecast
14.2 Asia Pacific
14.2.1 China
14.2.1.1 Market Trends
14.2.1.2 Market Forecast
14.2.2 Japan
14.2.2.1 Market Trends
14.2.2.2 Market Forecast
14.2.3 India
14.2.3.1 Market Trends
14.2.3.2 Market Forecast
14.2.4 South Korea
14.2.4.1 Market Trends
14.2.4.2 Market Forecast
14.2.5 Australia
14.2.5.1 Market Trends
14.2.5.2 Market Forecast
14.2.6 Others
14.2.6.1 Market Trends
14.2.6.2 Market Forecast
14.3 Europe
14.3.1 Germany
14.3.1.1 Market Trends
14.3.1.2 Market Forecast
14.3.2 France
14.3.2.1 Market Trends
14.3.2.2 Market Forecast
14.3.3 United Kingdom
14.3.3.1 Market Trends
14.3.3.2 Market Forecast
14.3.4 Italy
14.3.4.1 Market Trends
14.3.4.2 Market Forecast
14.3.5 Spain
14.3.5.1 Market Trends
14.3.5.2 Market Forecast
14.3.6 Russia
14.3.6.1 Market Trends
14.3.6.2 Market Forecast
14.3.7 Others
14.3.7.1 Market Trends
14.3.7.2 Market Forecast
14.4 Latin America
14.4.1 Brazil
14.4.1.1 Market Trends
14.4.1.2 Market Forecast
14.4.2 Mexico
14.4.2.1 Market Trends
14.4.2.2 Market Forecast
14.4.3 Others
14.4.3.1 Market Trends
14.4.3.2 Market Forecast
14.5 Middle East and Africa
14.5.1 Turkey
14.5.1.1 Market Trends
14.5.1.2 Market Forecast
14.5.2 GCC Countries
14.5.2.1 Market Trends
14.5.2.2 Market Forecast
14.5.3 Israel
14.5.3.1 Market Trends
14.5.3.2 Market Forecast
14.5.4 Others
14.5.4.1 Market Trends
14.5.4.2 Market Forecast
15 SWOT Analysis
15.1 Overview
15.2 Strengths
15.3 Weaknesses
15.4 Opportunities
15.5 Threats
16 Value Chain Analysis
16.1 Exploratory Stage
16.2 Preclinical and Clinical Development
16.3 Regulatory Approval
16.4 Manufacturing
16.5 Marketing and Distribution
17 Porters Five Forces Analysis
17.1 Overview
17.2 Bargaining Power of Buyers
17.3 Bargaining Power of Suppliers
17.4 Degree of Competition
17.5 Threat of New Entrants
17.6 Threat of Substitutes
18 Price Analysis
19 Major Drivers and Challenges
20 Competitive Landscape
20.1 Market Structure
20.2 Key Players
20.3 Profiles of Key Players
20.3.1 Abbott Laboratories
20.3.1.1 Company Overview
20.3.1.2 Product Portfolio
20.3.1.3 Financials
20.3.1.4 SWOT Analysis
20.3.2 Astellas Pharma Inc.
20.3.2.1 Company Overview
20.3.2.2 Product Portfolio
20.3.2.3 Financials
20.3.2.4 SWOT Analysis
20.3.3 AstraZeneca Plc
20.3.3.1 Company Overview
20.3.3.2 Product Portfolio
20.3.3.3 Financials
20.3.3.4 SWOT Analysis
20.3.4 Bharat Biotech International
20.3.4.1 Company Overview
20.3.4.2 Product Portfolio
20.3.5 Bavarian Nordic A/S
20.3.5.1 Company Overview
20.3.5.2 Product Portfolio
20.3.5.3 Financials
20.3.6 CSL Limited
20.3.6.1 Company Overview
20.3.6.2 Product Portfolio
20.3.6.3 Financials
20.3.6.4 SWOT Analysis
20.3.7 Daiichi Sankyo Company Limited
20.3.7.1 Company Overview
20.3.7.2 Product Portfolio
20.3.8 Emergent BioSolutions Inc.
20.3.8.1 Company Overview
20.3.8.2 Product Portfolio
20.3.8.3 Financials
20.3.8.4 SWOT Analysis
20.3.9 GlaxoSmithKline Plc
20.3.9.1 Company Overview
20.3.9.2 Product Portfolio
20.3.9.3 Financials
20.3.9.4 SWOT Analysis
20.3.10 Inovio Pharmaceuticals Inc.
20.3.10.1 Company Overview
20.3.10.2 Product Portfolio
20.3.10.3 Financials
20.3.10.4 SWOT Analysis
20.3.11 Johnson & Johnson
20.3.11.1 Company Overview
20.3.11.2 Product Portfolio
20.3.11.3 Financials
20.3.11.4 SWOT Analysis
20.3.12 Merck & Co. Inc.
20.3.12.1 Company Overview
20.3.12.2 Product Portfolio
20.3.12.3 Financials
20.3.12.4 SWOT Analysis
20.3.13 Mitsubishi Tanabe Pharma Corporation (Mitsubishi Chemical Holdings Corporation)
20.3.13.1 Company Overview
20.3.13.2 Product Portfolio
20.3.13.3 Financials
20.3.13.4 SWOT Analysis
20.3.14 Novavax Inc.
20.3.14.1 Company Overview
20.3.14.2 Product Portfolio
20.3.14.3 Financials
20.3.14.4 SWOT Analysis
20.3.15 Panacea Biotec Ltd.
20.3.15.1 Company Overview
20.3.15.2 Product Portfolio
20.3.16 Pfizer Inc.
20.3.16.1 Company Overview
20.3.16.2 Product Portfolio
20.3.16.3 Financials
20.3.16.4 SWOT Analysis
20.3.17 Sanofi Pasteur SA (Sanofi SA)
20.3.17.1 Company Overview
20.3.17.2 Product Portfolio
20.3.17.3 Financials
20.3.17.4 SWOT Analysis
20.3.18 Serum Institute of India Pvt. Ltd.
20.3.18.1 Company Overview
20.3.18.2 Product Portfolio
20.3.19 Takeda Pharmaceutical Company Limited
20.3.19.1 Company Overview
20.3.19.2 Product Portfolio
20.3.19.3 Financials
20.3.19.4 SWOT Analysis
List of Figures
Figure 1: Global: Vaccine Market: Major Drivers and Challenges
Figure 2: Global: Vaccine Market: Sales Value (in Billion US$), 2014-2019
Figure 3: Global: Vaccine Market Forecast: Sales Value (in Billion US$), 2020-2025
Figure 4: Global: Vaccine Market: Breakup by Technology (in %), 2019
Figure 5: Global: Vaccine Market: Breakup by Patient Type (in %), 2019
Figure 6: Global: Vaccine Market: Breakup by Indication (in %), 2019
Figure 7: Global: Vaccine Market: Breakup by Route of Administration (in %), 2019
Figure 8: Global: Vaccine Market: Breakup by Product Type (in %), 2019
Figure 9: Global: Vaccine Market: Breakup by Treatment Type (in %), 2019
Figure 10: Global: Vaccine Market: Breakup by End User (in %), 2019
Figure 11: Global: Vaccine Market: Breakup by Distribution Channel (in %), 2019
Figure 12: Global: Vaccine Market: Breakup by Region (in %), 2019
Figure 13: Global: Vaccine (Conjugate Vaccines) Market: Sales Value (in Million US$), 2014 & 2019
Figure 14: Global: Vaccine (Conjugate Vaccines) Market Forecast: Sales Value (in Million US$), 2020-2025
Figure 15: Global: Vaccine (Inactivated and Subunit Vaccines) Market: Sales Value (in Million US$), 2014 & 2019
Figure 16: Global: Vaccine (Inactivated and Subunit Vaccines) Market Forecast: Sales Value (in Million US$), 2020-2025
Figure 17: Global: Vaccine (Live Attenuated Vaccines) Market: Sales Value (in Million US$), 2014 & 2019
Figure 18: Global: Vaccine (Live Attenuated Vaccines) Market Forecast: Sales Value (in Million US$), 2020-2025
Figure 19: Global: Vaccine (Recombinant Vaccines) Market: Sales Value (in Million US$), 2014 & 2019
Figure 20: Global: Vaccine (Recombinant Vaccines) Market Forecast: Sales Value (in Million US$), 2020-2025
Figure 21: Global: Vaccine (Toxoid Vaccines) Market: Sales Value (in Million US$), 2014 & 2019
Figure 22: Global: Vaccine (Toxoid Vaccines) Market Forecast: Sales Value (in Million US$), 2020-2025
Figure 23: Global: Vaccine (Other Technologies) Market: Sales Value (in Million US$), 2014 & 2019
Figure 24: Global: Vaccine (Other Technologies) Market Forecast: Sales Value (in Million US$), 2020-2025
Figure 25: Global: Vaccine (Paediatric) Market: Sales Value (in Million US$), 2014 & 2019
Figure 26: Global: Vaccine (Paediatric) Market Forecast: Sales Value (in Million US$), 2020-2025
Figure 27: Global: Vaccine (Adult) Market: Sales Value (in Million US$), 2014 & 2019
Figure 28: Global: Vaccine (Adult) Market Forecast: Sales Value (in Million US$), 2020-2025
Figure 29: Global: Vaccine (Bacterial Diseases) Market: Sales Value (in Million US$), 2014 & 2019
Figure 30: Global: Vaccine (Bacterial Diseases) Market Forecast: Sales Value (in Million US$), 2020-2025
Figure 31: Global: Vaccine (Meningococcal Disease) Market: Sales Value (in Million US$), 2014 & 2019
Figure 32: Global: Vaccine (Meningococcal Disease) Market Forecast: Sales Value (in Million US$), 2020-2025
Figure 33: Global: Vaccine (Pneumococcal Disease) Market: Sales Value (in Million US$), 2014 & 2019
Figure 34: Global: Vaccine (Pneumococcal Disease) Market Forecast: Sales Value (in Million US$), 2020-2025
Figure 35: Global: Vaccine (Diphtheria/Tetanus/Pertussis (DPT)) Market: Sales Value (in Million US$), 2014 & 2019
Figure 36: Global: Vaccine (Diphtheria/Tetanus/Pertussis (DPT)) Market Forecast: Sales Value (in Million US$), 2020-2025
Figure 37: Global: Vaccine (Tuberculosis) Market: Sales Value (in Million US$), 2014 & 2019
Figure 38: Global: Vaccine (Tuberculosis) Market Forecast: Sales Value (in Million US$), 2020-2025
Figure 39: Global: Vaccine (Haemophilus Influenzae (Hib)) Market: Sales Value (in Million US$), 2014 & 2019
Figure 40: Global: Vaccine (Haemophilus Influenzae (Hib)) Market Forecast: Sales Value (in Million US$), 2020-2025
Figure 41: Global: Vaccine (Typhoid) Market: Sales Value (in Million US$), 2014 & 2019
Figure 42: Global: Vaccine (Typhoid) Market Forecast: Sales Value (in Million US$), 2020-2025
Figure 43: Global: Vaccine (Other Bacterial Diseases) Market: Sales Value (in Million US$), 2014 & 2019
Figure 44: Global: Vaccine (Other Bacterial Diseases) Market Forecast: Sales Value (in Million US$), 2020-2025
Figure 45: Global: Vaccine (Viral Diseases) Market: Sales Value (in Million US$), 2014 & 2019
Figure 46: Global: Vaccine (Viral Diseases) Market Forecast: Sales Value (in Million US$), 2020-2025
Figure 47: Global: Vaccine (Hepatitis) Market: Sales Value (in Million US$), 2014 & 2019
Figure 48: Global: Vaccine (Hepatitis) Market Forecast: Sales Value (in Million US$), 2020-2025
Figure 49: Global: Vaccine (Influenza) Market: Sales Value (in Million US$), 2014 & 2019
Figure 50: Global: Vaccine (Influenza) Market Forecast: Sales Value (in Million US$), 2020-2025
Figure 51: Global: Vaccine (Human Papillomavirus (HPV)) Market: Sales Value (in Million US$), 2014 & 2019
Figure 52: Global: Vaccine (Human Papillomavirus (HPV)) Market Forecast: Sales Value (in Million US$), 2020-2025
Figure 53: Global: Vaccine (Measles/Mumps/Rubella (MMR)) Market: Sales Value (in Million US$), 2014 & 2019
Figure 54: Global: Vaccine (Measles/Mumps/Rubella (MMR)) Market Forecast: Sales Value (in Million US$), 2020-2025
Figure 55: Global: Vaccine (Rotavirus) Market: Sales Value (in Million US$), 2014 & 2019
Figure 56: Global: Vaccine (Rotavirus) Market Forecast: Sales Value (in Million US$), 2020-2025
Figure 57: Global: Vaccine (Herpes Zoster) Market: Sales Value (in Million US$), 2014 & 2019
Figure 58: Global: Vaccine (Herpes Zoster) Market Forecast: Sales Value (in Million US$), 2020-2025
Figure 59: Global: Vaccine (Varicella) Market: Sales Value (in Million US$), 2014 & 2019
Figure 60: Global: Vaccine (Varicella) Market Forecast: Sales Value (in Million US$), 2020-2025
Figure 61: Global: Vaccine (Japanese Encephalitis) Market: Sales Value (in Million US$), 2014 & 2019
Figure 62: Global: Vaccine (Japanese Encephalitis) Market Forecast: Sales Value (in Million US$), 2020-2025
Figure 63: Global: Vaccine (Rubella) Market: Sales Value (in Million US$), 2014 & 2019
Figure 64: Global: Vaccine (Rubella) Market Forecast: Sales Value (in Million US$), 2020-2025
Figure 65: Global: Vaccine (Polio) Market: Sales Value (in Million US$), 2014 & 2019
Figure 66: Global: Vaccine (Polio) Market Forecast: Sales Value (in Million US$), 2020-2025
Figure 67: Global: Vaccine (Rabies) Market: Sales Value (in Million US$), 2014 & 2019
Figure 68: Global: Vaccine (Rabies) Market Forecast: Sales Value (in Million US$), 2020-2025
Figure 69: Global: Vaccine (Dengue) Market: Sales Value (in Million US$), 2014 & 2019
Figure 70: Global: Vaccine (Dengue) Market Forecast: Sales Value (in Million US$), 2020-2025
Figure 71: Global: Vaccine (Other Viral Diseases) Market: Sales Value (in Million US$), 2014 & 2019
Figure 72: Global: Vaccine (Other Viral Diseases) Market Forecast: Sales Value (in Million US$), 2020-2025
Figure 73: Global: Vaccine (Intramuscular and Subcutaneous Administration) Market: Sales Value (in Million US$), 2014 & 2019
Figure 74: Global: Vaccine (Intramuscular and Subcutaneous Administration) Market Forecast: Sales Value (in Million US$), 2020-2025
Figure 75: Global: Vaccine (Oral Administration) Market: Sales Value (in Million US$), 2014 & 2019
Figure 76: Global: Vaccine (Oral Administration) Market Forecast: Sales Value (in Million US$), 2020-2025
Figure 77: Global: Vaccine (Other Routes of Administration) Market: Sales Value (in Million US$), 2014 & 2019
Figure 78: Global: Vaccine (Other Routes of Administration) Market Forecast: Sales Value (in Million US$), 2020-2025
Figure 79: Global: Vaccine (Multivalent Vaccine) Market: Sales Value (in Million US$), 2014 & 2019
Figure 80: Global: Vaccine (Multivalent Vaccine) Market Forecast: Sales Value (in Million US$), 2020-2025
Figure 81: Global: Vaccine (Monovalent Vaccine) Market: Sales Value (in Million US$), 2014 & 2019
Figure 82: Global: Vaccine (Monovalent Vaccine) Market Forecast: Sales Value (in Million US$), 2020-2025
Figure 83: Global: Vaccine (Preventive Vaccine) Market: Sales Value (in Million US$), 2014 & 2019
Figure 84: Global: Vaccine (Preventive Vaccine) Market Forecast: Sales Value (in Million US$), 2020-2025
Figure 85: Global: Vaccine (Therapeutic Vaccine) Market: Sales Value (in Million US$), 2014 & 2019
Figure 86: Global: Vaccine (Therapeutic Vaccine) Market Forecast: Sales Value (in Million US$), 2020-2025
Figure 87: Global: Vaccine (Hospitals) Market: Sales Value (in Million US$), 2014 & 2019
Figure 88: Global: Vaccine (Hospitals) Market Forecast: Sales Value (in Million US$), 2020-2025
Figure 89: Global: Vaccine (Clinics) Market: Sales Value (in Million US$), 2014 & 2019
Figure 90: Global: Vaccine (Clinics) Market Forecast: Sales Value (in Million US$), 2020-2025
Figure 91: Global: Vaccine (Vaccination Centres) Market: Sales Value (in Million US$), 2014 & 2019
Figure 92: Global: Vaccine (Vaccination Centres) Market Forecast: Sales Value (in Million US$), 2020-2025
Figure 93: Global: Vaccine (Academic and Research Institutes) Market: Sales Value (in Million US$), 2014 & 2019
Figure 94: Global: Vaccine (Academic and Research Institutes) Market Forecast: Sales Value (in Million US$), 2020-2025
Figure 95: Global: Vaccine (Other End Users) Market: Sales Value (in Million US$), 2014 & 2019
Figure 96: Global: Vaccine (Other End Users) Market Forecast: Sales Value (in Million US$), 2020-2025
Figure 97: Global: Vaccine (Hospital Pharmacies) Market: Sales Value (in Million US$), 2014 & 2019
Figure 98: Global: Vaccine (Hospital Pharmacies) Market Forecast: Sales Value (in Million US$), 2020-2025
Figure 99: Global: Vaccine (Retail Pharmacies) Market: Sales Value (in Million US$), 2014 & 2019
Figure 100: Global: Vaccine (Retail Pharmacies) Market Forecast: Sales Value (in Million US$), 2020-2025
Figure 101: Global: Vaccine (Institutional Sales) Market: Sales Value (in Million US$), 2014 & 2019
Figure 102: Global: Vaccine (Institutional Sales) Market Forecast: Sales Value (in Million US$), 2020-2025
Figure 103: Global: Vaccine (Other Distribution Channels) Market: Sales Value (in Million US$), 2014 & 2019
Figure 104: Global: Vaccine (Other Distribution Channels) Market Forecast: Sales Value (in Million US$), 2020-2025
Figure 105: North America: Vaccine Market: Sales Value (in Million US$), 2014 & 2019
Figure 106: North America: Vaccine Market Forecast: Sales Value (in Million US$), 2020-2025
Figure 107: United States: Vaccine Market: Sales Value (in Million US$), 2014 & 2019
Figure 108: United States: Vaccine Market Forecast: Sales Value (in Million US$), 2020-2025
Figure 109: Canada: Vaccine Market: Sales Value (in Million US$), 2014 & 2019
Figure 110: Canada: Vaccine Market Forecast: Sales Value (in Million US$), 2020-2025
Figure 111: Asia Pacific: Vaccine Market: Sales Value (in Million US$), 2014 & 2019
Figure 112: Asia Pacific: Vaccine Market Forecast: Sales Value (in Million US$), 2020-2025
Figure 113: China: Vaccine Market: Sales Value (in Million US$), 2014 & 2019
Figure 114: China: Vaccine Market Forecast: Sales Value (in Million US$), 2020-2025
Figure 115: Japan: Vaccine Market: Sales Value (in Million US$), 2014 & 2019
Figure 116: Japan: Vaccine Market Forecast: Sales Value (in Million US$), 2020-2025
Figure 117: India: Vaccine Market: Sales Value (in Million US$), 2014 & 2019
Figure 118: India: Vaccine Market Forecast: Sales Value (in Million US$), 2020-2025
Figure 119: South Korea: Vaccine Market: Sales Value (in Million US$), 2014 & 2019
Figure 120: South Korea: Vaccine Market Forecast: Sales Value (in Million US$), 2020-2025
Figure 121: Australia: Vaccine Market: Sales Value (in Million US$), 2014 & 2019
Figure 122: Australia: Vaccine Market Forecast: Sales Value (in Million US$), 2020-2025
Figure 123: Others: Vaccine Market: Sales Value (in Million US$), 2014 & 2019
Figure 124: Others: Vaccine Market Forecast: Sales Value (in Million US$), 2020-2025
Figure 125: Europe: Vaccine Market: Sales Value (in Million US$), 2014 & 2019
Figure 126: Europe: Vaccine Market Forecast: Sales Value (in Million US$), 2020-2025
Figure 127: Germany: Vaccine Market: Sales Value (in Million US$), 2014 & 2019
Figure 128: Germany: Vaccine Market Forecast: Sales Value (in Million US$), 2020-2025
Figure 129: France: Vaccine Market: Sales Value (in Million US$), 2014 & 2019
Figure 130: France: Vaccine Market Forecast: Sales Value (in Million US$), 2020-2025
Figure 131: United Kingdom: Vaccine Market: Sales Value (in Million US$), 2014 & 2019
Figure 132: United Kingdom: Vaccine Market Forecast: Sales Value (in Million US$), 2020-2025
Figure 133: Italy: Vaccine Market: Sales Value (in Million US$), 2014 & 2019
Figure 134: Italy: Vaccine Market Forecast: Sales Value (in Million US$), 2020-2025
Figure 135: Spain: Vaccine Market: Sales Value (in Million US$), 2014 & 2019
Figure 136: Spain: Vaccine Market Forecast: Sales Value (in Million US$), 2020-2025
Figure 137: Russia: Vaccine Market: Sales Value (in Million US$), 2014 & 2019
Figure 138: Russia: Vaccine Market Forecast: Sales Value (in Million US$), 2020-2025
Figure 139: Others: Vaccine Market: Sales Value (in Million US$), 2014 & 2019
Figure 140: Others: Vaccine Market Forecast: Sales Value (in Million US$), 2020-2025
Figure 141: Latin America: Vaccine Market: Sales Value (in Million US$), 2014 & 2019
Figure 142: Latin America: Vaccine Market Forecast: Sales Value (in Million US$), 2020-2025
Figure 143: Brazil: Vaccine Market: Sales Value (in Million US$), 2014 & 2019
Figure 144: Brazil: Vaccine Market Forecast: Sales Value (in Million US$), 2020-2025
Figure 145: Mexico: Vaccine Market: Sales Value (in Million US$), 2014 & 2019
Figure 146: Mexico: Vaccine Market Forecast: Sales Value (in Million US$), 2020-2025
Figure 147: Others: Vaccine Market: Sales Value (in Million US$), 2014 & 2019
Figure 148: Others: Vaccine Market Forecast: Sales Value (in Million US$), 2020-2025
Figure 149: Middle East and Africa: Vaccine Market: Sales Value (in Million US$), 2014 & 2019
Figure 150: Middle East and Africa: Vaccine Market Forecast: Sales Value (in Million US$), 2020-2025
Figure 151: Turkey: Vaccine Market: Sales Value (in Million US$), 2014 & 2019
Figure 152: Turkey: Vaccine Market Forecast: Sales Value (in Million US$), 2020-2025
Figure 153: GCC Countries: Vaccine Market: Sales Value (in Million US$), 2014 & 2019
Figure 154: GCC Countries: Vaccine Market Forecast: Sales Value (in Million US$), 2020-2025
Figure 155: Israel: Vaccine Market: Sales Value (in Million US$), 2014 & 2019
Figure 156: Israel: Vaccine Market Forecast: Sales Value (in Million US$), 2020-2025
Figure 157: Others: Vaccine Market: Sales Value (in Million US$), 2014 & 2019
Figure 158: Others: Vaccine Market Forecast: Sales Value (in Million US$), 2020-2025
Figure 159: Global: Vaccine Industry: SWOT Analysis
Figure 160: Global: Vaccine Industry: Value Chain Analysis
Figure 161: Global: Vaccine Industry: Porter’s Five Forces Analysis
List of Tables
Table 1: Global: Vaccine Market: Key Industry Highlights, 2019 and 2025
Table 2: Global: Vaccine Market Forecast: Breakup by Technology (in Million US$), 2020-2025
Table 3: Global: Vaccine Market Forecast: Breakup by Patient Type (in Million US$), 2020-2025
Table 4: Global: Vaccine Market Forecast: Breakup by Indication (in Million US$), 2020-2025
Table 5: Global: Vaccine Market Forecast: Breakup by Route of Administration (in Million US$), 2020-2025
Table 6: Global: Vaccine Market Forecast: Breakup by Product Type (in Million US$), 2020-2025
Table 7: Global: Vaccine Market Forecast: Breakup by Treatment Type (in Million US$), 2020-2025
Table 8: Global: Vaccine Market Forecast: Breakup by End User (in Million US$), 2020-2025
Table 9: Global: Vaccine Market Forecast: Breakup Distribution Channel (in Million US$), 2020-2025
Table 10: Global: Vaccine Market Forecast: Breakup by Region (in Million US$), 2020-2025
Table 11: Global: Vaccine Market: Competitive Structure
Table 12: Global: Vaccine Market: Key Players